We develop drugs that target only the diseased organs. We have two Orphan drug Designations from EMA: in liver and brain cancer. Less complications, more effect

Double Bond Pharmaceutical AB
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttps://www.doublebp.com
Founded2014
Disease Focus
Development Stage
STOCK CODENon Listed
AddressVirdings all_ 32B, 75 450UppsalaSweden
Virdings all_ 32B, 75 450
Uppsala
Sweden
Contact Number+46 73570 02 03
+46 73570 02 03
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/double-bond-pharmaceutical” connections=”true” suffix=””]